Chemotherapy of Metastatic Breast Cancer: Is more better?

By Jassem Jacek  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 37-42

Springer Publishing Company

Access to resources Recommend Favorite

Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas

By Dummer Reinhard   Rozati Sima   Guenova Emmanuella   Cozzio Antonio  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1061-1064

Future Medicine

Access to resources Recommend Favorite

Epidemiology of AIDS-related tumours in developed and developing countries

By Dal Maso L.   Serraino D.   Franceschi S.  

European Journal of Cancer, Vol. 37, Iss. 10, 2001-07 ,pp. : 1188-1201

Elsevier

Access to resources Recommend Favorite

How can we improve survival from breast cancer in developing countries?

By Sankaranarayanan Rengaswamy   Alwan Nada   Denny Lynette  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 179-183

Future Medicine

Access to resources Recommend Favorite

Downregulation of BCSG1 may correlate with better outcome of neoadjuvant chemotherapy for triple-negative breast cancer

By                  

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1209-1212

Spandidos Publications

Access to resources Recommend Favorite